Portman Square Capital LLP Boston Scientific Corp Transaction History
Portman Square Capital LLP
- $2.36 Billion
- Q4 2024
A detailed history of Portman Square Capital LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Portman Square Capital LLP holds 60,300 shares of BSX stock, worth $6.19 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
60,300Holding current value
$6.19 Million% of portfolio
0.23%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BSX
# of Institutions
1,572Shares Held
1.18BCall Options Held
6.82MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$13.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$6.45 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.89 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$3.37 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...